Electrophysiological Characterization of AMPA and NMDA Receptors in Rat Dorsal Striatum

  • Jeun, Seung-Hyun (Department of Pharmacology, Medical Research Center for Cell Death Disease Research Center, The Catholic University of Korea) ;
  • Cho, Hyeong-Seok (Department of Pharmacology, Medical Research Center for Cell Death Disease Research Center, The Catholic University of Korea) ;
  • Kim, Ki-Jung (Department of Pharmacology, Medical Research Center for Cell Death Disease Research Center, The Catholic University of Korea) ;
  • Li, Qing-Zhong (Department of Pharmacology, Medical Research Center for Cell Death Disease Research Center, The Catholic University of Korea) ;
  • Sung, Ki-Wug (Department of Pharmacology, Medical Research Center for Cell Death Disease Research Center, The Catholic University of Korea)
  • Published : 2009.06.30

Abstract

The striatum receives glutamatergic afferents from the cortex and thalamus, and these synaptic transmissions are mediated by ${\alpha}$-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) and N-methyl D-aspartate (NMDA) receptors. The purpose of this study was to characterize glutamate receptors by analyzing NMDA/AMPA ratio and rectification of AMPA and NMDA excitatory postsynaptic currents (EPSCs) using a whole-cell voltage-clamp method in the dorsal striatum. Receptor antagonists were used to isolate receptor or subunit specific EPSC, such as (DL)-2-amino-5-phosphonovaleric acid (APV), an NMDA receptor antagonist, ifenprodil, an NR2B antagonist, CNQX, an AMPA receptor antagonist and IEM-1460, a GluR2-lacking AMPA receptor blocker. AMPA and NMDA EPSCs were recorded at - 70 and + 40 mV, respectively. Rectification index was calculated by current ratio of EPSCs between + 50 and - 50 mV. NMDA/AMPA ratio was 0.20${\pm}$0.05, AMPA receptor ratio of GluR2-lacking/GluR2-containing subunit was 0.26${\pm}$0.05 and NMDA receptor ratio of NR2B/NR2A subunit was 0.32${\pm}$0.03. The rectification index (control 2.39${\pm}$0.27) was decreased in the presence of both APV and combination of APV and IEM-1460 (1.02${\pm}$0.11 and 0.93${\pm}$0.09, respectively). These results suggest that the major components of the striatal glutamate receptors are GluR2-containing AMPA receptors and NR2A-containing NMDA receptors. Our results may provide useful information for corticostriatal synaptic transmission and plasticity studies.

Keywords

References

  1. Adesnik H, Nicoll RA. Conservation of glutamate receptor 2-containing AMPA receptors during long-term potentiation. J Neurosci 27: 4598−4602, 2007 https://doi.org/10.1523/JNEUROSCI.0325-07.2007
  2. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31−39, 1993 https://doi.org/10.1038/361031a0
  3. Buldakova SL, Kim KK, Tikhonov DB, Magazanik LG. Selective blockade of $Ca^{2+}$ permeable AMPA receptors in CA1 area of rat hippocampus. Neuroscience 144: 88−99, 2007 https://doi.org/10.1016/j.neuroscience.2006.09.005
  4. Cho HS, Lee HH, Choi SJ, Kim KJ, Jeun SH, Li QZ, Sung KW. Forskolin enhances synaptic transmission in rat dorsal striatum though NMDA receptors and PKA in different phases. Korean J Physiol Pharmacol 12: 293−297, 2008 https://doi.org/10.4196/kjpp.2008.12.6.293
  5. Choi SJ, Kim KJ, Cho HS, Kim SY, Cho YJ, Hahn SJ, Sung KW. Acute inhibition of corticostriatal synaptic transmission in the rat dorsal striatum by ethanol. Alcohol 40: 95−101, 2006 https://doi.org/10.1016/j.alcohol.2006.12.004
  6. Derkach VA, Oh MC, Guire ES, Soderling TR. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci 8: 101−113, 2007 https://doi.org/10.1038/nrn2055
  7. Ding J, Peterson JD, Surmeier DJ. Corticostriatal and thalamostriatal synapses have distinctive properties. J Neurosci 28: 6483−6492, 2008 https://doi.org/10.1523/JNEUROSCI.0435-08.2008
  8. Du J, Creson TK, Wu LJ, Ren M, Gray NA, Falke C, Wei Y, Wang Y, Blumenthal R, Machado-Vieira R, Yuan P, Chen G, Zhuo M, Manji HK. The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci 28: 68−79, 2008 https://doi.org/10.1523/JNEUROSCI.3080-07.2008
  9. Greger IH, Khatri L, Ziff EB. RNA editing at arg607 controls AMPA receptor exit from the endoplasmic reticulum. Neuron 34: 759−772, 2002 https://doi.org/10.1016/S0896-6273(02)00693-1
  10. Jonas P, Burnashev N. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 15: 987−990, 1995 https://doi.org/10.1016/0896-6273(95)90087-X
  11. Kreitzer AC, Malenka RC. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445: 643−647, 2007 https://doi.org/10.1038/nature05506
  12. au CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8: 413−426, 2007 https://doi.org/10.1038/nrn2153
  13. Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson YP, Wang YT. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304: 1021−1024, 2004 https://doi.org/10.1126/science.1096615
  14. Massey PV, Johnson BE, Moult PR, Auberson YP, Brown MW, Molnar E, Collingridge GL, Bashir ZI. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci 24: 7821−7828, 2004 https://doi.org/10.1523/JNEUROSCI.1697-04.2004
  15. McDermott CM, Hardy MN, Bazan NG, Magee JC. Sleep deprivation-induced alterations in excitatory synaptic transmission in the CA1 region of the rat hippocampus. J Physiol 570: 553−565, 2006
  16. Nansen EA, Jokel ES, Lobo MK, Micevych PE, Ariano MA, Levine MS. Striatal ionotropic glutamate receptor ontogeny in the rat. Dev Neurosci 22: 329−340, 2000 https://doi.org/10.1159/000017457
  17. Panicker S, Brown K, Nicoll RA. Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2- lacking mouse. Proc Natl Acad Sci U S A 105: 1032−1037, 2008 https://doi.org/10.1073/pnas.0711313105
  18. Parsons CG, Danysz W, Quack G. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect 11: 523−569, 1998 https://doi.org/10.1358/dnp.1998.11.9.863689
  19. Schotanus SM, Chergui K. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl- D-aspartate receptors. Eur J Neurosci 27: 1957−1964, 2008 https://doi.org/10.1111/j.1460-9568.2008.06173.x
  20. Standaert DG, Testa CM, Young AB, Penney JB, Jr. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343: 1−16, 1994 https://doi.org/10.1002/cne.903430102
  21. Sung KW, Choi S, Lovinger DM. Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J Neurophysiol 86: 2405−2412, 2001
  22. Tardin C, Cognet L, Bats C, Lounis B, Choquet D. Direct imaging of lateral movements of AMPA receptors inside synapses. EMBO J 22: 4656−4665, 2003 https://doi.org/10.1093/emboj/cdg463
  23. Wang YH, Bosy TZ, Yasuda RP, Grayson DR, Vicini S, Pizzorusso T, Wolfe BB. Characterization of NMDA receptor subunit- specific antibodies: distribution of NR2A and NR2B receptor subunits in rat brain and ontogenic profile in the cerebellum. J Neurochem 65: 176−183, 1995 https://doi.org/10.1046/j.1471-4159.1995.65010176.x
  24. Weitlauf C, Honse Y, Auberson YP, Mishina M, Lovinger DM, Winder DG. Activation of NR2A-containing NMDA receptors is not obligatory for NMDA receptor-dependent long-term potentiation. J Neurosci 25: 8386−8390, 2005 https://doi.org/10.1523/JNEUROSCI.2388-05.2005